Fig. 5From: Probabilistic cost-effectiveness analysis of controlled ovarian stimulation with recombinant FSH plus recombinant LH vs. human menopausal gonadotropin for women undergoing IVFCost-effectiveness Acceptability Curve – ≥ 5 retrieved oocytes. CE Cost effectivenessBack to article page